Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Innate immunity to herpes simplex virus type 2.

Rebecca J Duerst1, Lynda A Morrison

  • 1Department of Molecular Microbiology and Immunology, Saint Louis University School of Medicine, Missouri 63104, USA.

Viral Immunology
|January 22, 2004
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

ICP8-vhs- HSV-2 Vaccine Expressing B7 Costimulation Molecules Optimizes Safety and Efficacy against HSV-2 Infection in Mice.

Viruses·2023
Same author

Antiviral activity of amide-appended α-hydroxytropolones against herpes simplex virus-1 and -2.

RSC advances·2023
Same author

Synthetic derivatives of the antifungal drug ciclopirox are active against herpes simplex virus 2.

European journal of medicinal chemistry·2022
Same author

Efficacy of an HSV-1 Neuro-Attenuated Vaccine in Mice Is Reduced by Preventing Viral DNA Replication.

Viruses·2022
Same author

Neutralizing Antibody Kinetics and Immune Protection Against Herpes Simplex Virus 1 Genital Disease in Vaccinated Women.

The Journal of infectious diseases·2022
Same author

Synthesis of Polyoxygenated Tropolones and their Antiviral Activity against Hepatitis B Virus and Herpes Simplex Virus-1.

Chemistry (Weinheim an der Bergstrasse, Germany)·2022
Same journal

Reovirus Reassortants Reveal Context-Dependent Oncolytic Phenotypes Across Epithelial Cancer Cell Lines.

Viral immunology·2026
Same journal

Syncytia Formation in the Pathogenesis of SARS-CoV-2 Infection: Lessons from Viral Infections.

Viral immunology·2026
Same journal

Screening and Characterization of Nanobody Against the Emerging Dairy Cattle H5N1 Influenza Virus.

Viral immunology·2026
Same journal

Immunoinformatics-Driven Design of a Multiepitope Vaccine for Rustrela Virus-Induced Neurological Diseases: A New Frontier in Encephalitis and Meningoencephalitis Prevention.

Viral immunology·2026
Same journal

Single-Cell Transcriptomic Profiling Reveals Molecular Alterations in the Airway Epithelial Cells of Children with Wheezing Infected by Respiratory Syncytial Virus.

Viral immunology·2026
Same journal

Effect of Pentoxifylline on Inflammatory Markers in COVID-19: A Meta-Analysis of Randomized Controlled Trials.

Viral immunology·2026
See all related articles

Herpes simplex virus type 2 (HSV-2) causes genital herpes and newborn disease. This review details how innate immunity fights HSV-2 and how the virus evades these defenses.

Area of Science:

  • Immunology
  • Virology
  • Infectious Diseases

Background:

  • Herpes simplex virus type 2 (HSV-2) is a primary cause of genital herpes and can lead to severe neonatal disease.
  • HSV-2 infections begin at mucosal surfaces and rapidly establish latency in peripheral nerves.
  • Innate immunity is critical for controlling initial viral replication and shaping the adaptive immune response during HSV-2 infection.

Purpose of the Study:

  • To review the innate immune responses mounted against HSV-2.
  • To elucidate the mechanisms HSV-2 employs to evade innate immunity.
  • To discuss the interplay between innate immune products and adaptive immune development.

Main Methods:

  • Literature review of innate immunity and HSV-2 interactions.
  • Analysis of viral evasion strategies.

Related Experiment Videos

  • Synthesis of current research on immune responses.

    • Main Results:

    • Innate immunity comprises multifaceted defenses including physical barriers, soluble factors (chemokines, interferons), and cellular components.
    • HSV-2 has evolved sophisticated mechanisms to counteract and subvert these innate defenses.
    • Emerging evidence highlights connections between innate immune signaling and the subsequent adaptive immune response.

    Conclusions:

    • Understanding innate immunity's role and HSV-2's evasion tactics is crucial for developing effective antiviral strategies.
    • Further research into the innate-adaptive immune crosstalk can reveal new therapeutic targets.
    • This review consolidates current knowledge on the complex battle between HSV-2 and the host innate immune system.